The Room Was Already Full
The buyer is not more sophisticated than the rep. The buyer is more current. Those are two different problems, and the information gap between them is free to close.
AdvaMed confirmed that 69% of U.S. medical devices are manufactured outside the country. When import duties climbed to 145% on select categories, hospital procurement committees across the country started moving. Not slowly. Preferred vendor decisions shifted. Capital commitments were deferred. Purchasing timelines changed.
Most medtech reps learned about it from buyers. After procurement had already started moving.
That is not a story about uninformed reps. The tariff announcement was public. The procurement response was predictable. The gap between when the buyer acted and when the rep knew about it, that is the problem this issue is built around.
The Mechanic in Its Purest Form
The coffee on the conference room table had been sitting there long enough that nobody was pouring it anymore. Sarah noticed this without deciding to. Nine years in surgical robotics will train you to read a room fast, and the first thing she read was that these seven people had already been in several conversations before she arrived.
She had been preparing for three weeks. The kind of preparing where you run the ROI narrative in your car, where you send yourself the slide deck at 11 PM to double-check the clinical evidence sequence, where you ask a colleague to play devil's advocate on competitive pricing because you know the account is evaluating a competing platform. She was as ready as her organization knew how to make her.
The supply chain director opened before she could.
"You know the GPO window on your category closes in eleven days, right?"
Sarah did not know. Not because she had not prepared. Because her organization does not have a system that moves publicly available procurement intelligence to the reps who need it. The GPO calendar had been on the supply chain director's desk for six weeks. Printed. Posted. Governing the shape of this deal more completely than any product feature, any clinical outcome, any pricing negotiation.
The buyer is not more sophisticated than the rep. The buyer is more current. Those are two different problems.
The Scale of It
McKinsey's 2024 commercial excellence research puts a number on the gap. Companies with designed information flows, not just trained behaviors, grow at 1.4 times the market rate. In medtech, the data is specific: top-quartile commercial organizations posted 11.2% CAGR between 2019 and 2023. The average was 6.1%. Bottom quartile: 4.2%. That is a 7-point spread, compounding over five years.
McKinsey is explicit about the driver. It is not talent. It is not product. It is information architecture.
The average hospital buying decision now involves 6.8 stakeholders. The average medtech rep has a meaningful relationship with 1.4 of them. The committee built a scoring rubric before the meeting. The rep walks in without having seen it.
When it happens with a tariff signal, you feel it in win rates. When it happens with a GPO expiration, you feel it in deal velocity. When it happens with a reimbursement change, you feel it in contract renewals. Same mechanic. Every quarter. At scale.
What Was Actually in the Room
The information Sarah needed was not classified. It was not locked behind a regulatory database requiring specialized training. The GPO calendar is distributed to member health systems. The CMS Final Rule publishes on an annual public schedule. Hospital earnings transcripts are on the investor relations page, findable in under four minutes. VAC scoring frameworks are discussable, some health systems post them, if someone asks the right person the right question before the meeting.
The information is free. The room is already full of it. The question is whether your commercial organization has built the habit of reading the same documents your buyers read before the relevant meeting, or whether you are expected to find them on your own, every time, in the margins of an already full week.
The diagnostic question the whole system turns on is this:
What did our buyers read this week that we have not?
If you can answer it, someone in your organization has been reading the signals and moving the intelligence. You walked into a meeting this week a step ahead of the conversation instead of a step behind it.
If you cannot answer it, if the question produces silence, or a vague gesture toward a sales portal nobody opens, or a competitive brief last updated in Q3, you know exactly where the design failure is. The gap is not talent. The gap is the answer to that question.
Dr. Gunter Wessels is the founder of LiquidSMARTS℠, a commercial engineering firm for medical technology companies. LiquidSMARTS℠ guarantees 10% pipeline velocity improvement in 90 days.